{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:44:35Z","timestamp":1785887075210,"version":"3.56.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2314-B-038-050"],"award-info":[{"award-number":["NSTC 113-2314-B-038-050"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC113-2314-B-182A-020"],"award-info":[{"award-number":["NSTC113-2314-B-182A-020"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biopha.2026.119703","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T19:47:42Z","timestamp":1782935262000},"page":"119703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeted attenuation of liver fibrosis using microbubble-enhanced protease-activated receptor 1 chimeric antigen receptor T cells"],"prefix":"10.1016","volume":"201","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8830-3679","authenticated-orcid":false,"given":"Hao-Chien","family":"Hung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainani Priza","family":"Minhalina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5744-0678","authenticated-orcid":false,"given":"Po-Jung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Hung","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3452-9660","authenticated-orcid":false,"given":"Ting-Yen","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao Lien","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10308","key":"10.1016\/j.biopha.2026.119703_bib1","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gines","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2026.119703_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"issue":"10406","key":"10.1016\/j.biopha.2026.119703_bib3","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0140-6736(23)01174-1","article-title":"Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study","volume":"402","author":"Serra-Burriel","year":"2023","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.biopha.2026.119703_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147873","article-title":"Liver fibrosis: from basic science towards clinical progress, focusing on the central role of hepatic stellate cells","volume":"25","author":"Akkiz","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2026.119703_bib5","doi-asserted-by":"crossref","first-page":"C789","DOI":"10.1152\/ajpcell.00230.2013","article-title":"Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis","volume":"305","author":"Mallat","year":"2013","journal-title":"Am. J. Physiol. Cell. Physiol."},{"issue":"20","key":"10.1016\/j.biopha.2026.119703_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012572","article-title":"The molecular mechanisms of liver fibrosis and its potential therapy in application","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2026.119703_bib7","doi-asserted-by":"crossref","first-page":"755","DOI":"10.4254\/wjh.v15.i6.755","article-title":"Treatment of liver fibrosis: past, current, and future","volume":"15","author":"Zhang","year":"2023","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.biopha.2026.119703_bib8","unstructured":"F.D.A. Orange Book."},{"issue":"4","key":"10.1016\/j.biopha.2026.119703_bib9","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/j.2040-4603.2013.tb00529.x","article-title":"Hepatic stellate cells and liver fibrosis","volume":"3","author":"Puche","year":"2013","journal-title":"Compr. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119703_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2026.119703_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.14309\/ajg.0000000000000486","article-title":"ACG clinical guideline: disorders of the hepatic and mesenteric circulation","volume":"115","author":"Simonetto","year":"2020","journal-title":"Am. J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119703_bib12","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.jtha.2023.03.017","article-title":"vivo generation of thrombin in patients with liver disease without apparent evidence of activation of the intrinsic or extrinsic pathway of coagulation","volume":"21","author":"Elvers","year":"2023","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.biopha.2026.119703_bib13","doi-asserted-by":"crossref","first-page":"G171","DOI":"10.1152\/ajpgi.00402.2017","article-title":"Role of the blood coagulation cascade in hepatic fibrosis","volume":"315","author":"Pant","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119703_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cells7080085","article-title":"Coagulation, microenvironment and liver fibrosis","volume":"7","author":"Bitto","year":"2018","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.biopha.2026.119703_bib15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hep.20054","article-title":"PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation","volume":"39","author":"Fiorucci","year":"2004","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2026.119703_bib16","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0168-8278(01)00285-9","article-title":"Regulation of hepatic stellate cell proliferation and collagen synthesis by proteinase-activated receptors","volume":"36","author":"Gaca","year":"2002","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119703_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086241","article-title":"Proteinase activated receptor 1 mediated fibrosis in a mouse model of liver injury: a role for bone marrow derived macrophages","volume":"9","author":"Kallis","year":"2014","journal-title":"PLoS. One"},{"issue":"9","key":"10.1016\/j.biopha.2026.119703_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092567","article-title":"The landscape of CAR-T cell clinical trials against solid tumors-a comprehensive overview","volume":"12","author":"Schaft","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.biopha.2026.119703_bib19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41576-021-00329-9","article-title":"Genetic engineering of T cells for immunotherapy","volume":"22","author":"Ellis","year":"2021","journal-title":"Nat. Rev. Genet."},{"issue":"10","key":"10.1016\/j.biopha.2026.119703_bib20","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.addr.2008.03.005","article-title":"Microbubbles in ultrasound-triggered drug and gene delivery","volume":"60","author":"Hernot","year":"2008","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119703_bib21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2018.04.012","article-title":"Prolonging pulse duration in ultrasound-mediated gene delivery lowers acoustic pressure threshold for efficient gene transfer to cells and small animals","volume":"279","author":"Tran","year":"2018","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.biopha.2026.119703_bib22","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/RLI.0b013e3182982cc1","article-title":"Ultrasound and microbubble-mediated gene delivery in cancer: progress and perspectives","volume":"48","author":"Panje","year":"2013","journal-title":"Invest. Radiol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119703_bib23","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/gt.2015.25","article-title":"Gene delivery to the spinal cord using MRI-guided focused ultrasound","volume":"22","author":"Weber-Adrian","year":"2015","journal-title":"Gene Ther."},{"issue":"6","key":"10.1016\/j.biopha.2026.119703_bib24","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1517\/14712598.2016.1169268","article-title":"Prospect of ultrasound-mediated gene delivery in cardiovascular applications","volume":"16","author":"Chen","year":"2016","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2026.119703_bib25","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.3892\/mmr.2015.4054","article-title":"Gene therapy for ocular diseases meditated by ultrasound and microbubbles (Review)","volume":"12","author":"Wan","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2026.119703_bib26","article-title":"Advances in ultrasound-assisted drug delivery and clinical application","volume":"124","author":"Lai","year":"2025","journal-title":"Ultrason. Sonochem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119703_bib27","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s12916-023-03053-9","article-title":"Effect of chimeric antigen receptor T cells against protease-activated receptor 1 for treating pancreatic cancer","volume":"21","author":"Hung","year":"2023","journal-title":"BMC Med."},{"issue":"4","key":"10.1016\/j.biopha.2026.119703_bib28","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.ymthe.2024.02.010","article-title":"Ultrasound-mediated gene delivery specifically targets liver sinusoidal endothelial cells for sustained FVIII expression in hemophilia A mice","volume":"32","author":"Lawton","year":"2024","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.biopha.2026.119703_bib29","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/gt.2017.73","article-title":"Impact of germline and somatic BRCA1\/2 mutations: tumor spectrum and detection platforms","volume":"24","author":"Wu","year":"2017","journal-title":"Gene Ther."},{"issue":"2","key":"10.1016\/j.biopha.2026.119703_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/PAP.0000000000000139","article-title":"Immunohistochemistry and special stains in medical liver pathology","volume":"24","author":"Clark","year":"2017","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.biopha.2026.119703_bib31","unstructured":"Rasband W.S. Image J. US National Institutes of Health, Bethesda, Maryland, USA. 1997\u20132012. \u3008http:\/\/imagej.nih.gov\/ij\/\u3009."},{"key":"10.1016\/j.biopha.2026.119703_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2025.105015","article-title":"A synergy of CD133 overexpression and TGF-beta supplementation in tumorigenesis of ovarian cancer cell lines in a three-dimensional sphere forming model","volume":"417","author":"Hung","year":"2025","journal-title":"Cell. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119703_bib33","article-title":"Present and future perspectives in the treatment of liver fibrosis","volume":"18","author":"Cerrito","year":"2025","journal-title":"Pharm. (Basel)"},{"key":"10.1016\/j.biopha.2026.119703_bib34","doi-asserted-by":"crossref","first-page":"9641","DOI":"10.2147\/IJN.S524078","article-title":"Nanomedicines in the treatment of liver fibrosis: a review","volume":"20","author":"Du","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119703_bib35","article-title":"TGF-beta inhibitors: the future for prevention and treatment of liver fibrosis?","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119703_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1574385","article-title":"Mechanism-guided drug development and treatment for liver fibrosis: a clinical perspective","volume":"16","author":"Zeng","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119703_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/jpps.2023.11808","article-title":"Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches","volume":"26","author":"Mohammed","year":"2023","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119703_bib38","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1038\/s41467-025-59138-x","article-title":"Structural basis for the activation of proteinase-activated receptors PAR1 and PAR2","volume":"16","author":"Lyu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119703_bib39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.thromres.2020.08.004","article-title":"The domino effect triggered by the tethered ligand of the protease activated receptors","volume":"196","author":"Han","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.biopha.2026.119703_bib40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jconrel.2023.01.052","article-title":"Liver fibrosis therapy based on biomimetic nanoparticles which deplete activated hepatic stellate cells","volume":"355","author":"Xia","year":"2023","journal-title":"J. Control. Release"},{"issue":"27","key":"10.1016\/j.biopha.2026.119703_bib41","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.3748\/wjg.v11.i27.4167","article-title":"Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation","volume":"11","author":"Chang","year":"2005","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119703_bib42","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1038\/s41598-023-30582-3","article-title":"Mangiferin relieves CCl4-induced liver fibrosis in mice","volume":"13","author":"Zhang","year":"2023","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2026.119703_bib43","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1089\/hum.2017.243","article-title":"Preclinical models in chimeric antigen receptor-engineered T-cell therapy","volume":"29","author":"Siegler","year":"2018","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119703_bib44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10875-007-9159-y","article-title":"Autoimmunity in severe combined immunodeficiency (SCID): lessons from patients and experimental models","volume":"28","author":"Milner","year":"2008","journal-title":"J. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119703_bib45","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.apsb.2017.02.004","article-title":"Advances in ultrasound-targeted microbubble-mediated gene therapy for liver fibrosis","volume":"7","author":"Huang","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"issue":"11","key":"10.1016\/j.biopha.2026.119703_bib46","doi-asserted-by":"crossref","first-page":"711","DOI":"10.5152\/tjg.2025.25313","article-title":"Liver fibrosis: interactions between cells and microenvironments","volume":"36","author":"Zou","year":"2025","journal-title":"Turk. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2026.119703_bib47","article-title":"The pivotal role of TGF-beta\/Smad pathway in fibrosis pathogenesis and treatment","volume":"15","author":"Chen","year":"2025","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119703_bib48","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/febs.13665","article-title":"TGF-beta signalling and liver disease","volume":"283","author":"Fabregat","year":"2016","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.biopha.2026.119703_bib49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1369\/0022155415627681","article-title":"TGF-beta\/SMAD pathway and its regulation in hepatic fibrosis","volume":"64","author":"Xu","year":"2016","journal-title":"J. Histochem. Cytochem."},{"issue":"9","key":"10.1016\/j.biopha.2026.119703_bib50","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1074\/jbc.RA118.005761","article-title":"Transforming growth factor beta (TGFbeta) cross-talk with the unfolded protein response is critical for hepatic stellate cell activation","volume":"294","author":"Liu","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.biopha.2026.119703_bib51","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201263R","article-title":"Early-immediate gene Egr1 is associated with TGFbeta1 regulation of epigenetic reader Bromodomain-containing protein 4 via the canonical Smad3 signaling in hepatic stellate cells in vitro and in vivo","volume":"36","author":"Tian","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2026.119703_bib52","article-title":"Signaling pathways that activate hepatic stellate cells during liver fibrosis","volume":"11","author":"Zhang","year":"2024","journal-title":"Front. Med. (Lausanne)"},{"issue":"11","key":"10.1016\/j.biopha.2026.119703_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111419","article-title":"TGF-beta in hepatic stellate cell activation and liver fibrogenesis-updated 2019","volume":"8","author":"Dewidar","year":"2019","journal-title":"Cells"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:52:28Z","timestamp":1785883948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226007390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":53,"alternative-id":["S0753332226007390"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119703","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted attenuation of liver fibrosis using microbubble-enhanced protease-activated receptor 1 chimeric antigen receptor T cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119703"}}